Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

7 Biggest Lithium-mining Companies in 2024

A State-by-State Guide to Cannabis in Australia (Updated 2024)

Hydrogen Stocks: 9 Biggest Companies in 2024

Can You Invest in Elon Musk’s Neuralink? (Updated 2024)

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

Top 10 Gold-mining Companies (Updated 2024)

Rare Earths Stocks: 9 Biggest Companies in 2024

Keith Weiner: US$2,700 Gold, US$36 Silver? Modeling Fundamental Prices

Trending Press Releases

Westgold Strategic Alliance and Placement

Charbone Hydrogen is More Than Doubling its Phase 1 Electrolyzer Capacity to Power Up Green Hydrogen Production at the Sorel-Tracy, Quebec Plant

Aston Bay and American West Metals Announce C$17.1 Million Royalty Package for the Storm Copper Project, Canada

Radiopharm Theranostics Completes A$70 Million Placement

Zodiac Gold Completes Pre-Drilling Satellite Data Interpretation at the Alasala Target on the Todi Gold Project

Balkan Mining and Minerals Limited (ASX: BMM) – Trading Halt

More Press Releases
Trending Companies

Ora Gold Limited

OAU:AU

Sona Nanotech

SONA:CNX

Galan Lithium

GLN:AU

Antilles Gold Limited

AAU:AU
More Companies
Trending Reports

2024 Gold Outlook Report

2024 Lithium Market Outlook (Updated for Q2)

2024 Copper Outlook Report

2024 Graphite Outlook Report

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold Price
Silver Price
Copper Price
Oil Price
Uranium
Artificial Intelligence
loader

Aligos Therapeutics Inc.

NASDAQ:ALGS
Press Releases

Aligos Therapeutics Presents Positive Data at the EASL Congress 2024

Aligos Therapeutics Announces Six Abstracts Accepted for Presentation at EASL 2024

Aligos Therapeutics Announces the Completion of Enrollment in the ALG-055009 Phase 2a HERALD Study for the Treatment of MASH

Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

Interactive Chart

×